Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE003859 |
ID: | TCMBANKHE003859 |
药用植物名: | 南五味子 |
治疗类型: | 收涩药 |
SymMap_id: | 299 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000040 | jujuboside a | jujuboside A; JuA; Jujuboside A1; 2-[(4-{[4,5-DIHYDROXY-6-({[3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}METHYL)-3-[(3,4,5-TRIHYDROXYOXAN-2-YL)OXY]OXAN-2-YL]OXY}-5-HYDROXY-2-{[16-HYDROXY-2,6,6,10,16-PENTAMETHYL-18-(2-METHYLPROP-1-EN-1-YL)-19,21-DIOXAHEXACYCLO[18.2.1.0(1),(1)?.0(2),(1)(1).0?,(1)?.0(1)?,(2)?]TRICOSAN-7-YL]OXY}OXAN-3-YL)OXY]-6-METHYLOXANE-3,4,5-TRIOL; 2-[(4-{[4,5-dihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-5-hydroxy-2-{[16-hydroxy-2,6,6,10,16-pentamethyl-18-(2-methylprop-1-en-1-yl)-19,21-dioxahexacyclo[18.2.1.0;{1,14}.0;{2,11}.0;{5,10}.0;{15,20}]tricosan-7-yl]oxy}oxan-3-yl)oxy]-6-methyloxane-3,4,5-triol | C58H94O26 | 1207.3 g/mol | CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C7C(CC(OC78CC6(C5(CCC4C3(C)C)C)CO8)C=C(C)C)(C)O)C)O)OC9C(C(C(C(O9)COC1C(C(C(C(O1)CO)O)O)O)O)O)OC1C(C(C(CO1)O)O)O)O)O)O |
| TCMBANKIN002550 | leucocyanidin | (2R,3R,4R)-2-(3,4-DIHYDROXYPHENYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-3,4,5,7-TETROL; ZINC4096940; (2R)-2alpha-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3alpha,4alpha,5,7-tetrol; 867061-09-4 | C15H14O7 | 306.27 g/mol | C1=CC(=C(C=C1C2C(C(C3=C(C=C(C=C3O2)O)O)O)O)O)O |
| TCMBANKIN002615 | schisanlactone E | schisanlactone e | C30H44O4 | 468.67 | CC1=CCC(OC1=O)C(C)C2CCC3(C2(CCC45C3CCC(C4(C5)CCC(=O)O)C(=C)C)C)C |
| TCMBANKIN004857 | sorbitol | S0900_SIGMA; 8036-93-9; LS-188010; S8143_SIGMA; 85529_FLUKA; Sorbitol FP; 8013-15-8; 15060-73-8; 63800-20-4; 3959-53-3; Sorbitol F solution; Karion instant; S7547_SIGMA; CCRIS 1898; S6021_SIGMA; Multitol; FEMA No. 3029; 47841_SUPELCO; NSC 25944; D00096; EINECS 200-061-5; 36134-87-9; 75398-79-7; Neosorb P 20/60; CHEBI:17924; W302902_ALDRICH; Neosorb 70/02; Hexahydric alcohol; Sorbitol (NF); Foodol D 70; D-Sorbit; Neosorb P 60; 8045-74-7; SOR; Glucarine; Sorbitol solutions; 8046-05-7; Sionit K; D-Sorbitol (JP15); 97336_FLUKA; ZINC02042995; 1,2,3,4,5,6-Hexanehexol; S1876_SIGMA; Sorbitol F; 309532_ALDRICH; Neosorb 20/60DC; 8014-89-9; (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol; Sorbitol 3% in plastic container; S3889_SIGMA; 8042-39-5; Sorbitol 3% in plastic container (TN); HSDB 801; AI3-19424; (-)-Sorbitol; D-Sorbite; Neosorb 70/70; Karion (carbohydrate); 98201-93-5 | C6H14O6 | 182.17 | C(C(C(C(C(CO)O)O)O)O)O |
| TCMBANKIN008636 | acetylcholine | Vagusstoff; AC1NSTAT; Acetylcholine Hydroxide; 2-acetyloxyethyl(trimethyl)azanium hydroxide; SCHEMBL3904052; 56-13-3 | C7H16NO2+ | 146.21 g/mol | CC(=O)OCC[N+](C)(C)C |
| TCMBANKIN011889 | angusifolin B | 562.61 | |||
| TCMBANKIN013261 | ceanothic acid | NCGC00168838-03_C30H46O5_(1R,2S,5aR,5bR,7aS,10R,12bR)-2-Hydroxy-10-isopropenyl-3,3,5a,5b,12b-pentamethyloctadecahydrodicyclopenta[a,i]phenanthrene-1,7a(1H)-dicarboxylic acid; (1R,2R,5S,8R,14R,15R,16S)-16-HYDROXY-1,2,14,17,17-PENTAMETHYL-8-(PROP-1-EN-2-YL)PENTACYCLO[11.7.0.0(2),(1)?.0?,?.0(1)?,(1)?]ICOSANE-5,15-DICARBOXYLIC ACID; ACon0_000328; ACon1_000054; MolPort-001-741-019; ceanothicacid; NCGC00168838-01; NP-002508; MEGxp0_000866 | C30H46O5 | 486.68 | CC(=C)C1CCC2(C1C3CCC4C(C3(CC2)C)(CCC5C4(C(C(C5(C)C)O)C(=O)O)C)C)C(=O)O |
| TCMBANKIN014614 | jujuboside b | jujuboside B; DTXSID80670023; AKOS015965496; Jujuboside-B; JujubosideB; AN-40319; PUBCHEM_45358134; AC-20265 | C52H84O21 | 1045.2 g/mol | CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C5CCC6C(C5(CCC4C3(C)C)C)CC78C6C(CC(O7)(OC8)C=C(C)C)(C)O)C)O)OC9C(C(C(C(O9)CO)O)O)OC1C(C(C(CO1)O)O)O)O)O)O |
| TCMBANKIN016581 | neokadsuranic acid C | neokadsuranicacid c; neokadsuranic acid c; AC1NSZ1V; (Z)-6-[(11bS)-4,4,6b,11b-tetramethyl-10-methylidene-3-oxo-1,2,4a,5,6,7,8,9,10a,11-decahydrobenzo[a]fluoren-9-yl]-2-methylhept-2-enoic acid | C30H46O4 | 470.68 | CC(CCC=C(C)C(=O)O)C1CCC2(C(C1(C)O)CC3=C2CCC4C3(CCC(=O)C4(C)C)C)C |
| TCMBANKIN025521 | angusifolin C | 520.57 | |||
| TCMBANKIN031144 | Neokadsuranic acid B | neokadsuranic acid b; neokadsuranic acid B; neokadsuranicacid b | C30H44O3 | 452.7 g/mol | CC(CCC=C(C)C(=O)O)C1CCC2(C(C1=C)CC3=C2CCC4C3(CCC(=O)C4(C)C)C)C |
| TCMBANKIN031921 | leucodelphinidin | Leucodelphinidin; CHEMBL460265 | C15H14O8 | 322.27 | C1=C(C=C(C(=C1O)O)O)C2C(C(C3=C(C=C(C=C3O2)O)O)O)O |
| TCMBANKIN034419 | kadsurin | Kadsurin; 51670-40-7; [tetramethoxy(dimethyl)[?]yl] acetate; Benzo(3,4)cycloocta(1,2-f)(1,3)benzodioxol-8-ol, 5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-, acetate, stereoisomer (VAN) | C25H30O8 | 458.5 | CC1CC2=CC(=C(C(=C2C3=C(C4=C(C=C3C(C1C)OC(=O)C)OCO4)OC)OC)OC)OC |
| TCMBANKIN035108 | ebelin lactone | C30H46O3 | 454.7 g/mol | CC(=CC=CC(=CC1CCC2C3(CCC(C(C3CCC2(C14CC(=O)OC4)C)(C)C)O)C)C)C | |
| TCMBANKIN035698 | angusifolin A | 624.68 | |||
| TCMBANKIN037373 | Heteroclitin D | heteroclitin d | 482.52 | ||
| TCMBANKIN037727 | Changnanic acid | changnanicacid | 468.67 | ||
| TCMBANKIN037904 | Kadsulignan C | kadsulignan c | C31H30O11 | 578.56 | CC1C(C2=CC3=C(C4=C2C5(CO4)C(=CC(=C(C5=O)OC)OC)C(C1(C)O)OC(=O)C)OCO3)OC(=O)C6=CC=CC=C6 |
| TCMBANKIN038204 | ferulic acid | (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; caffeic acid 3-methyl ether; ferulicacid; A803063; (E)-3-(4-Hydroxy-3-methoxyphenyl)-2-propenoate; CJ-00500; ZB002373; ferulate; CHEBI:29749; (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate; 3-Methoxy-4-hydroxy-trans-cinnamate; (E)-3-(3-methoxy-4-oxidanyl-phenyl)prop-2-enoate; Ferulic Acid; AC1NUT2L; ferulic acid | C10H10O4 | 194.18 | COC1=C(C=CC(=C1)C=CC(=O)O)[O-] |
| TCMBANKIN039203 | Neokadsuranin | 414.45 | |||
| TCMBANKIN039983 | Schisanlactone A | schisanlactone a | 464.64 | ||
| TCMBANKIN039994 | kadsulignan A | kadsulignan a | C23H28O7 | 416.46 | CC1CC2=CC(=O)C(=C(C23C4=C(C(=C(C=C4C(C1C)O3)OC)OC)OC)OC)OC |
| TCMBANKIN041149 | Schisanlactone B | schisanlactone b | 466.7 g/mol | ||
| TCMBANKIN041160 | Schisantherin J | schisantherin j | 636.69 | ||
| TCMBANKIN041192 | Kadsulignan G | kadsulignan g | C32H36O11 | 596.62 | CC=C(C)C(=O)OC1C(C(C(C2=CC(=O)C(=C(C23COC4=C3C1=CC5=C4OCO5)OC)OC)OC(=O)C(=CC)C)(C)O)C |
| TCMBANKIN041345 | Interiotherin B | interiotherin b | C27H30O9 | 498.52 | CC=C(C)C(=O)OC1C2=CC3=C(C(=C2C4=C(C5=C(C=C4CC(C1(C)O)C)OCO5)OC)OC)OCO3 |
| TCMBANKIN041554 | Schisantherin L | schisantherin l | 498.52 | ||
| TCMBANKIN041901 | spinosin | (2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL (1S,4R,5R,9R,10S,13R)-13-{[(2S,3R,4S,5S,6R)-4,5-DIHYDROXY-6-(HYDROXYMETHYL)-3-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}OXAN-2-YL]OXY}-5,9-DIMETHYL-14-METHYLIDENETETRACYCLO[11.2.1.0(1),(1)?.0?,?]HEXADECANE-5-CARBOXYLATE; 6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-methylol-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-chromone; 6-(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4H-1-benzopyran-4-one; ZINC250859376; BG01794006; MolPort-006-131-346; SCHEMBL15521912; AKOS015840141; 6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-chromen-4-one; 6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-4-chromenone; 2''-O-beta-D-Glucopyranosylswertisin; 4H-1-Benzopyran-4-one, 6-(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-; 72063-39-9; 6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxan-2-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-chromen-4-one; Spinosin; 6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one | C28H32O15 | 609 | [C@@]1([H])(O[C@]2([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O[C@@]2([H])c3c(OC([H])([H])[H])c([H])c(OC(c4c([H])c([H])c(O[H])c([H])c4[H])=C([H])C5=O)c5c3O[H])[C@]([H])(O[H])[C@@]([ H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O1 |
| TCMBANKIN041920 | Kadsulactone | 452.67 | |||
| TCMBANKIN043087 | Heteroclitin F | heteroclitin f | 514.52 | ||
| TCMBANKIN043886 | Schisantherin M | schisantherin m | 580.62 | ||
| TCMBANKIN044232 | schizandronic acid | schizandronicacid | C30H46O3 | 454.68 | CC(CCC=C(C)C(=O)O)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(=O)C5(C)C)C)C |
| TCMBANKIN044430 | heteroclitin A | heteroclitin a | C28H36O8 | 500.58 | CCC(C)C(=O)OC1C(C(CC2=CC(=C(C(=C2C3=C(C4=C(C=C13)OCO4)OC)OC)OC)OC)C)C |
| TCMBANKIN045015 | Heteroclitin C | heteroclitin c | 498.56 | ||
| TCMBANKIN045772 | Heteroclitin B | heteroclitin b | 498.56 | ||
| TCMBANKIN046221 | Taiwanschirin D | 530.6 g/mol | |||
| TCMBANKIN047148 | Kadsulignan B | kadsulignan b | 474.5 | ||
| TCMBANKIN047571 | Interiotherin A | interiotherin a | 504.53 | ||
| TCMBANKIN047652 | Schisanlactone F | schisanlactone f | 468.7 g/mol | ||
| TCMBANKIN048038 | heteroclitin E | heteroclitin e | C27H30O9 | 498.52 | CC=C(C)C(=O)OC1C(C(C(C2=CC(=C(C(=O)C23COC4=C3C1=CC5=C4OCO5)OC)OC)O)C)C |
| TCMBANKIN048221 | Kadsutherin | 468.54 | |||
| TCMBANKIN048552 | Heteroclitin G | heteroclitin g | 400.42 | ||
| TCMBANKIN048628 | Kadsulignan E | kadsulignan e | 578.56 | ||
| TCMBANKIN049230 | Kadsulignan D | kadsulignan d | C32H36O11 | 596.62 | CC=C(C)C(=O)OC1C(C(C(C2=CC(=C(C(=O)C23COC4=C3C1=CC5=C4OCO5)OC)OC)OC(=O)C(=CC)C)(C)O)C |
| TCMBANKIN050021 | Kadsulignan F | kadsulignan f | C29H32O11 | 556.56 | CC=C(C)C(=O)OC1C2=CC(=O)C(=C(C23COC4=C3C(=CC5=C4OCO5)C(C(C1(C)O)C)OC(=O)C)OC)OC |
| TCMBANKIN058701 | alphitotic acid | Alphitolic acid; alphitolic acid; 2α,3β-dihydroxyl-lup-20(29)-en-28(19)-lactone; 2α,3α-dihydroxylup-20(29)-en-28-oicacid; alphitolicacid; NCGC00169506-02_C30H48O4_(2alpha,3beta,5xi,9xi,13xi,18xi)-2,3-Dihydroxylup-20(29)-en-28-oic acid | C30H48O4 | 472.7 | CC(=C)C1CCC2(C1C3CCC4C(C3(CC2)C)(CCC5C4(CC(C(C5(C)C)O)O)C)C)C(=O)O |
| TCMBANKIN058706 | betulin | AKOS025402304; Ambotz473-98-3; betulin ; AC-7983; SCHEMBL9888462; (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol; FVWJYYTZTCVBKE-MAIYTPNSSA-N; ; Trochol; 18211-63-7; C08618; Messagenin; 473-98-3; AIDS002710; B9757_SIGMA; ZINC03978650; Prestwick3_000990; Betulin; MEGxp0_001726; AI3-62999; BSPBio_001059; Lup-20(30)-ene-3beta,28-diol; C08631; Betulinol; ACon1_000091; AIDS-002710; Lup-20(29)-ene-3beta,28-diol; BPBio1_001165; Betuline; Lup-20(29)-ene-3,28-diol, (3beta)-; NSC 4644; (3.beta.)-Lup-20(29)-ene-3,28-diol; NSC692218; EINECS 207-475-5; Betulinic alcohol; ST5411404; Trochol | C30H50O2 | 442.7g/mol | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)O)C)CO |
| TCMBANKIN059329 | (+)-Anwulignan | SMR000445701; MLS000728494; 4-[(2S,3R)-4-(1,3-benzodioxol-5-yl)-2,3-dimethylbutyl]-2-methoxyphenol; 4-[(2S,3R)-4-(1,3-benzodioxol-5-yl)-2,3-dimethyl-butyl]-2-methoxy-phenol;macelignan | C20H24O4 | 328.4 g/mol | CC(CC1=CC2=C(C=C1)OCO2)C(C)CC3=CC(=C(C=C3)O)OC |
| TCMBANKIN059605 | 2α-hydroxyoleanolic acid;crategolicacid;2beta-hydroxyoleanolic acid;bredemolic acid;2a- hydroxy oleanolic acid;2α,3α-dihydroxyolean-12-en-28-oic acid;masilinic acid;(2β,3β)-maslinicacid;3-epimaslinic acid ;2α,3β-dihydroxyolean-12-en-28-oicacid;augustic acid ;Maslinic acid | C30H48O4 | 472.7 | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C)O)O)C)C)C2C1)C)C(=O)O)C | |
| TCMBANKIN059996 | Kadsulactone A | C30H42O5 | 482.65 | CC1=CCC(OC1=O)C(C)C2CCC3(C2(CCC45C3CC(C6C4(C5)C=CC(=O)OC6(C)C)O)C)C | |
| TCMBANKIN059997 | schisanlactone E | C30H44O4 | 468.67 | CC1=CCC(OC1=O)C(C)C2CCC3(C2(CCC45C3CCC(C4(C5)CCC(=O)O)C(=C)C)C)C | |
| TCMBANKIN061291 | creatine | C4H9N3O2 | 131.13 g/mol | CN(CC(=O)O)C(=N)N |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab